Funded Biotechnology Startups in Ireland
Among the 23 biotech rounds tracked here, Galway and Dublin together account for the majority of activity.
Among the 23 biotech rounds tracked here, Galway and Dublin together account for the majority of activity. Galway hosts a dense cluster: Luminate Medical ($17M venture round, November 2025), Vivasure Medical ($32M Series D, March 2023), Perfuze ($24M, March 2025), and Amara Therapeutics ($2M seed, May 2023) are all based there. Dublin anchors later-stage and pharma-focused companies — Neuromod Devices closed an $11M Series B in March 2025 while Carrick Therapeutics raised $35M in December 2022.
Round sizes span a wide spectrum. Perrigo's $2.6B post-IPO debt round and Normax Biomed's $301M venture raise from Cork sit at the high end, well above the dataset's typical sub-$25M raises. Five rounds closed in 2025 through November, with a combined disclosed total of at least $56M. Roughly a third of entries carry undisclosed amounts, a pattern concentrated at seed and series-unknown stages across cities including Dublin, Galway, Cork, and Limerick.
Most recent rounds
23 shownRelated listings
Frequently asked
What are the largest disclosed rounds in this dataset?
The three largest are Perrigo's $2.6B post-IPO debt round (Dublin, April 2022), Normax Biomed's $301M venture round (Cork, July 2022), and Trinity Biotech's $45M post-IPO equity raise (Bray, April 2022). Beyond those outliers, Carrick Therapeutics ($35M, December 2022) and Vivasure Medical ($32M Series D, March 2023) represent the upper end of the pre-IPO range.
Which cities host the most funded biotech startups in Ireland?
Dublin and Galway are the two dominant hubs. Dublin appears across 9 of the 23 entries, including Neuromod Devices, SOMAÍ Pharmaceuticals, and Carrick Therapeutics. Galway accounts for 7 entries, with Luminate Medical, Vivasure Medical, Perfuze, and Relevium Medical among them.
What round stages are most common among Irish biotech companies here?
Series Unknown and seed-stage rounds make up the plurality of entries, with several carrying undisclosed amounts. Series B appears three times — Neuromod Devices, SOMAÍ Pharmaceuticals, and Impedans. Only one Series D (Vivasure Medical, $32M) and one Series A (Ovagen, $2M) are recorded, indicating the dataset skews toward earlier and undefined stages.
How active was Irish biotech fundraising in 2025?
Five rounds closed in 2025 through November: Luminate Medical ($17M, Galway), Antler Bio ($4M seed, Dublin), Perfuze ($24M, Galway), Neuromod Devices ($11M Series B, Dublin), and Nemysis (undisclosed, Dublin). The four with disclosed figures total at least $56M.
Are there post-IPO companies represented in this segment?
Yes. Perrigo (Dublin) raised $2.6B via post-IPO debt in April 2022, and Trinity Biotech (Bray, Wicklow) raised $45M through post-IPO equity in the same month. Both are publicly listed companies that continued accessing capital markets well after their IPOs.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.